JANELL POTTS: Open Payments
NPI 1144239765 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 150 payments from 30 companies in 2025. Trend: 2023 $2,229 · 2024 $2,207 · 2025 $2,364
Food & beverage: $2,364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $335 |
| AstraZeneca Pharmaceuticals LP | 20 | $315 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $285 |
| PFIZER INC. | 15 | $175 |
| Amgen Inc. | 12 | $142 |
| Astellas Pharma US Inc | 6 | $117 |
| Alexion Pharmaceuticals, Inc. | 6 | $111 |
| Lundbeck LLC | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Exact Sciences Corporation | 4 | $74 |
Products named: CAPLYTA, AIRSUPRA, REXULTI, VRAYLAR, FARXIGA, Veozah, STRENSIQ, UBRELVY.
Industry payments across OH — which companies pay providers there.
